{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T08:54:25Z","timestamp":1649148865966},"reference-count":22,"publisher":"Japanese Leprosy Association","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn.J.Leprosy","Nihon Hansenbyo Gakkai Zasshi","Jpn J Lepr"],"published-print":{"date-parts":[[2010]]},"DOI":"10.5025\/hansen.79.275","type":"journal-article","created":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T06:21:31Z","timestamp":1328163691000},"page":"275-279","source":"Crossref","is-referenced-by-count":0,"title":[""],"prefix":"10.5025","volume":"79","member":"2941","reference":[{"issue":"3","key":"1","first-page":"219","volume":"80","author":"MIYACHI YOSHIKI","year":"1985","ISSN":"http:\/\/id.crossref.org\/issn\/0065-1176","issn-type":"print"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) \u5c3e\u5d0e\u5143\u662d:\u30b5\u30ea\u30c9\u30de\u30a4\u30c9\u3068\u30cf\u30f3\u30bb\u30f3\u75c5.\u65e5\u672c\u533b\u4e8b\u65b0\u5831 No 3942: 112-113,1999.","DOI":"10.5652\/kokusaikeizai.1999.112"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.5025\/hansen.71.3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Sheskin J: Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 6: 303-306, 1965.","DOI":"10.1002\/cpt196563303"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Pearson JM, Vedagiri M : Treatment of moderately severe erythema nodosum leprosum with thalidomide- a double-blind controlled trial. Lepr Rev 40, 111-116, 1969.","DOI":"10.5935\/0305-7518.19690022"},{"key":"6","unstructured":"6) Sheskin J, Convit J: Results of a double blind study of the influence of thalidomide on the lepra reaction. Int J Lepr 37, 135-146,1969."},{"key":"7","unstructured":"7) Iyer CG, Languillon J, Ramanujam K, Tarabini-Castellani G, De las Aguas JT, Bechelli LM, Uemura K, Martinez Dominguez V, Sundaresan T: WHO co-ordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromatous patients. Bull World Health Organ 45: 719-732, 1971."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Waters MF: An internally-controlled double blind trial of thalidomide in severe erythema nodosum leprosum. Lepr Rev 42, 26-42,1971.","DOI":"10.5935\/0305-7518.19710004"},{"key":"9","unstructured":"9) Iyer CG, Ramu G: An open trial with clofazimine in the management of recurrent lepra reaction using thalidomide as a control drug. Lepr India 48, 690-694, 1976."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Villahermosa LG, Fajardo TT Jr, Abalos RM, Balagon MV, Tan EV, Palmer JP, Wittes J, Thomas SD, Kook KA, Walsh GP, Walsh DS: A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum. Am J Trop Med Hyg 72: 518-526, 2005.","DOI":"10.4269\/ajtmh.2005.72.518"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Sales AM, de Matos HJ, Nery JA, Duppre NC, Sampaio EP, Sarno EN: Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosy. Braz J Med Biol Res 40: 243-248, 2007.","DOI":"10.1590\/S0100-879X2006005000070"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kaur I, Dogra S, Narang T, De D: Comparative efficacy of thalidomide and prednisolone in the treatment of moderate to severe erythema nodosum leprosum: a randomized study. Australas J Dermatol 50: 181-185, 2009.","DOI":"10.1111\/j.1440-0960.2009.00534.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Van Veen NH, Lockwood DN, Van Brakel WH, Ramirez J Jr, Richardus JH: Intervention for erythema nodosum leprosum. A Cochrane review. Lepr Rev 80: 355-372, 2009.","DOI":"10.1002\/14651858.CD006949.pub2"},{"key":"14","unstructured":"14) News:\u30b5\u30ea\u30c9\u30de\u30a4\u30c9 \u96e3\u6cbb\u6027\u75be\u60a3\u6cbb\u7642\u85ac\u3068\u3057\u3066\u3088\u307f\u304c\u3048\u308b.JAMA(\u65e5\u672c\u8a9e\u7248)42-44,1997(Dec)."},{"key":"15","unstructured":"15) FDA\u60c5\u5831;\u7669\u6027\u7d50\u7bc0\u6027\u7d05\u6591\u306e\u6cbb\u7642\u306b\u30b5\u30ea\u30c9\u30de\u30a4\u30c9\u304c\u627f\u8a8d\u3055\u308c\u308b.JAMA(\u65e5\u672c\u8a9e\u7248)61,1998(Nov)."},{"key":"16","unstructured":"16) Zeldis JB, Williams BA, Thomas SD, Elsayed ME: S.T.E.P.S.: A comprehensive program for controlling and monitoring access to thalidomide. Clin Ther 21: 319-330, 1999."},{"key":"17","unstructured":"17) \u65e5\u672c\u30cf\u30f3\u30bb\u30f3\u75c5\u5b66\u4f1a:\u30b5\u30ea\u30c9\u30de\u30a4\u30c9\u5185\u670d\u5264\u306e\u30cf\u30f3\u30bb\u30f3\u75c5\u6cbb\u7642\u85ac\u3068\u3057\u3066\u306e\u63aa\u7f6e\u9858\u3044.\u65e5\u30cf\u30f3\u30bb\u30f3\u75c5\u4f1a\u8a8c72: 293-294,2003."},{"key":"18","doi-asserted-by":"publisher","DOI":"10.5025\/hansen.75.191"},{"key":"19","unstructured":"19) \u65e5\u672c\u30cf\u30f3\u30bb\u30f3\u75c5\u5b66\u4f1a:\u8981\u671b\u66f8.\u65e5\u30cf\u30f3\u30bb\u30f3\u75c5\u4f1a\u8a8c78:303,2009."},{"issue":"11","key":"20","first-page":"1689","volume":"39","author":"SUGAYA KAZUE","year":"1997","ISSN":"http:\/\/id.crossref.org\/issn\/0018-1404","issn-type":"print"},{"key":"21","unstructured":"21) \u6749\u6d66\u5178\u5b50\u3001\u677e\u672c\u4f73\u5b50\u3001\u4f0a\u85e4\u7531\u4f73\u3001\u5009\u77e5\u8cb4\u5fd7\u90ce\u3001\u5c0f\u585a\u96c4\u6c11\u3001\u6cb3\u539f\u90a6\u5149\u3001\u5009\u7530\u660e\u5f66\u3001\u4f0a\u85e4\u5229\u6839\u592a\u90ce\u3001\u677e\u5ca1\u6b63\u5178\u3001\u5c0f\u6797\u548c\u592b\u3001\u77e2\u5cf6\u5e79\u4e45\u3001\u548c\u6cc9\u771e\u8535:\u3089\u3044\u6027\u7d50\u7bc0\u6027\u7d05\u6591(ENL)\u3092\u4f34\u3063\u305f LL\u578b\u30cf\u30f3\u30bb\u30f3\u75c5\u306e1\u4f8b.\u76ae\u819a\u79d1\u7d00\u898193:658,1998."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Kawakami T, Tsutsumi Y, Mizoguchi M, Ishii N, Soma Y:Leprosy with hepatic involvement. Int J Dermatol 46: 348-349, 2007.","DOI":"10.1111\/j.1365-4632.2007.03203.x"}],"container-title":["JAPANESE JOURNAL OF LEPROSY"],"original-title":["\u30b5\u30ea\u30c9\u30de\u30a4\u30c9\u306e\u3089\u3044\u6027\u7d50\u7bc0\u6027\u7d05\u6591\u306b\u5bfe\u3059\u308b\u4fdd\u967a\u9069\u7528\u306b\u5411\u3051\u3066"],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T18:54:58Z","timestamp":1621536898000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/hansen\/79\/3\/79_3_275\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.5025\/hansen.79.275","relation":{},"ISSN":["1342-3681","1884-314X"],"issn-type":[{"value":"1342-3681","type":"print"},{"value":"1884-314X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}